Results 101 to 110 of about 5,561 (172)

Technology Access and Preferences for Smartphone App Interventions to Optimize Iron Chelation Therapy Adherence Among Adolescents, Young Adults, and Parents of Children Receiving Chronic Transfusions: Cross-Sectional Survey Study. [PDF]

JMIR Pediatr Parent
Reddy P, Locke M, Badawy S.
europepmc   +1 more source

The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload. [PDF]

J Clin Med
Pongamnuaykrit M, Tantiworawit A, Niprapan P, Punnachet T, Hantrakun N, Piriyakhuntorn P, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Charoenkwan P.   +11 more
europepmc   +1 more source

Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapy. [PDF]

Ther Adv Endocrinol Metab
Al-Sanabra OM, Abbas MA, Hazàa AA, Hazà WJ.   +3 more
europepmc   +1 more source

Impact of iron chelation therapy on mitochondrial function, vascular integrity and inflammation in transfusion-dependent myelodysplastic syndromes. [PDF]

Front Immunol
García-Delgado R, Moreno-Carrasco G, Carrasco-Gomariz M, García-Segovia S, Flores RMO, Torres-González J, Gallego-Fuillerat G, López-Villodres JA, Escamilla-Sánchez A.   +8 more
europepmc   +1 more source

CLPX acquires an iron-sulfur cluster to sustain mitochondrial proteostasis in cancer cells. [PDF]

Nat Commun
Huang C, Zhang Y, Gao H, Song Y, Hu S, Sun C, Duan S, Ma D, Jiang X, Liu G.   +9 more
europepmc   +1 more source

Iron-Responsive Deferasirox Release from Covalently Grafted Hydrogels on Microwires Extends Iron Chelation Time Scales. [PDF]

ACS Appl Mater Interfaces
Maleszka JA, Attah E, Tsironi I, Franklin M, Bernard B, Grant JL, Lee GM, Lewis M, Byrd S, Prasad A, Olivier JH.   +10 more
europepmc   +1 more source

Transfusion-Related Iron Overload in Children With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Addressing an Overlooked Treatment Complication. [PDF]

Cureus
Matijasic Stjepovic N, Kranjcec I, Resic A, Sila S, Cavar A, Ruzman L, Trbusic E, Stepan Giljevic J.   +7 more
europepmc   +1 more source

Antioxidant Effects of CoQ10 in Transfusion-Dependent β-Thalassemia Major Patients: Implications for Ferroptosis-Related Pathways. [PDF]

J Blood Med
Fekri K, Mirforoughi MM, Salehinajafabadi Y, Raeisi Shahraki H, Ershadi R, Rahmati S.   +5 more
europepmc   +1 more source

Pharmacokinetics and Drug Interactions. [PDF]

Pharmaceutics
Choi MK, Song IS.
europepmc   +1 more source

Identification of deferasirox as a human xanthine oxidase inhibitor. [PDF]

Life Med
Qi Y, He X, Wu X, Zhou T, Liang N, Jiao J, Chen Y, Yuan Y, Zhang Y, Wang Y, Liu Y, Ding Q.   +11 more
europepmc   +1 more source